Docosahexaenoic acid (DAPT) inhibits pro-angiogenic effects of breast cancer cells via down-regulating cellular and exosomal expression of angiogenic genes and microRNAs. Website: https://www.selleckchem.com/products/dabrafenib-gsk2118436.html